Lack of CD8 <sup>+</sup> T cell effector differentiation during priming mediates checkpoint blockade resistance in non–small cell lung cancer

Brendan Horton, Duncan M. Morgan, Noor Momin, Maria Zagorulya, Elen Torres-Mejia, Vidit Bhandarkar, K. Dane Wittrup, J. Christopher Love, Stefani Spranger

Science Immunology · 2021 · 129 citations · 83 references

DOIFull text

Open access

Concepts

Abstract

A lung cancer–specific form of CD8 + T cell dysfunction is established during T cell priming and contributes to ICB resistance.

References

83